Sander C.J. Verfaillie

4.6k total citations
59 papers, 1.9k citations indexed

About

Sander C.J. Verfaillie is a scholar working on Psychiatry and Mental health, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sander C.J. Verfaillie has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Psychiatry and Mental health, 32 papers in Physiology and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sander C.J. Verfaillie's work include Dementia and Cognitive Impairment Research (34 papers), Alzheimer's disease research and treatments (30 papers) and Functional Brain Connectivity Studies (16 papers). Sander C.J. Verfaillie is often cited by papers focused on Dementia and Cognitive Impairment Research (34 papers), Alzheimer's disease research and treatments (30 papers) and Functional Brain Connectivity Studies (16 papers). Sander C.J. Verfaillie collaborates with scholars based in Netherlands, Sweden and United Kingdom. Sander C.J. Verfaillie's co-authors include Philip Scheltens, Wiesje M. van der Flier, Bart N.M. van Berckel, Frederik Barkhof, Niels D. Prins, Charlotte E. Teunissen, Rik Ossenkoppele, Rosalinde E.R. Slot, Inge M.W. Verberk and Tessa Timmers and has published in prestigious journals such as NeuroImage, Neurology and Annals of Neurology.

In The Last Decade

Sander C.J. Verfaillie

57 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sander C.J. Verfaillie Netherlands	26	1.1k	1.0k	536	451	318	59	1.9k
Marina Boccardi Italy	27	1.0k 0.9×	760 0.8×	450 0.8×	399 0.9×	257 0.8×	65	1.9k
Yun Xu China	13	1.0k 0.9×	838 0.8×	628 1.2×	489 1.1×	399 1.3×	32	1.9k
Sylvia Villeneuve Canada	27	1.1k 1.0×	1.0k 1.0×	570 1.1×	340 0.8×	308 1.0×	102	2.2k
David S. Knopman United States	13	1.1k 1.0×	883 0.9×	530 1.0×	338 0.7×	234 0.7×	27	2.0k
Wenzhu Bi United States	6	1.0k 0.9×	1.3k 1.3×	470 0.9×	349 0.8×	264 0.8×	12	1.8k
Panagiotis Alexopoulos Germany	29	1.2k 1.1×	945 0.9×	522 1.0×	340 0.8×	339 1.1×	110	2.6k
Meredith N. Braskie United States	28	676 0.6×	768 0.8×	638 1.2×	407 0.9×	265 0.8×	79	2.0k
J‐Sebastian Muehlboeck Sweden	22	1.0k 0.9×	712 0.7×	623 1.2×	378 0.8×	486 1.5×	41	1.8k
Nicolas Villain France	19	1.2k 1.1×	1.3k 1.3×	880 1.6×	481 1.1×	390 1.2×	68	2.7k
Cristina Testa Italy	22	814 0.7×	574 0.6×	586 1.1×	363 0.8×	250 0.8×	37	1.7k

Countries citing papers authored by Sander C.J. Verfaillie

Since Specialization

Citations

This map shows the geographic impact of Sander C.J. Verfaillie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander C.J. Verfaillie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander C.J. Verfaillie more than expected).

Fields of papers citing papers by Sander C.J. Verfaillie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander C.J. Verfaillie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander C.J. Verfaillie. The network helps show where Sander C.J. Verfaillie may publish in the future.

Co-authorship network of co-authors of Sander C.J. Verfaillie

This figure shows the co-authorship network connecting the top 25 collaborators of Sander C.J. Verfaillie. A scholar is included among the top collaborators of Sander C.J. Verfaillie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander C.J. Verfaillie. Sander C.J. Verfaillie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Visser, Denise, Pythia T. Nieuwkerk, Esmée Verwijk, et al.. (2025). Long-term cognitive functioning following COVID-19: Negligible neuropsychological changes over time. The Clinical Neuropsychologist. 40(1). 109–127.

Coomans, Emma M., Sander C.J. Verfaillie, Denise Visser, et al.. (2023). Performance of a [ ¹⁸ F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies. Neurology. 101(19). e1850–e1862. 11 indexed citations

Visser, Denise, Sander C.J. Verfaillie, Iman Brouwer, et al.. (2023). Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 50(8). 2409–2419. 2 indexed citations

Verfaillie, Sander C.J., Thérèse van Amelsvoort, Arne Popma, et al.. (2023). The Effects of a Digital, Transdiagnostic, Clinically and Peer-Moderated Treatment Platform for Young People With Emerging Mental Health Complaints: Repeated Measures Within-Subjects Study. JMIR mhealth and uhealth. 11. e50636–e50636. 3 indexed citations

Verfaillie, Sander C.J., Annemiek Dols, Mardien L. Oudega, et al.. (2023). Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex. EJNMMI Research. 13(1). 71–71. 5 indexed citations

Visser, Denise, Sander C.J. Verfaillie, Emma E. Wolters, et al.. (2022). Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 49(6). 1951–1963. 11 indexed citations

Heeman, Fiona, Denise Visser, Maqsood Yaqub, et al.. (2022). Precision estimates of relative and absolute cerebral blood flow in Alzheimer’s disease and cognitively normal individuals. Journal of Cerebral Blood Flow & Metabolism. 43(3). 369–378. 4 indexed citations

Timmers, Tessa, Emma E. Wolters, Rik Ossenkoppele, et al.. (2021). Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [18F]Flortaucipir and [18F]Florbetapir Brain PET Studies. Molecular Imaging and Biology. 23(4). 550–559. 2 indexed citations

Visser, Denise, Emma E. Wolters, Sander C.J. Verfaillie, et al.. (2020). Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 47(13). 3165–3175. 30 indexed citations

10.

Ebenau, Jarith L., Tessa Timmers, Linda M.P. Wesselman, et al.. (2020). ATN classification and clinical progression in subjective cognitive decline. Neurology. 95(1). e46–e58. 133 indexed citations

11.

Wolters, Emma E., Rik Ossenkoppele, Sandeep S.V. Golla, et al.. (2019). Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships. NeuroImage Clinical. 25. 102113–102113. 8 indexed citations

12.

Schrijvers, Rik, et al.. (2019). Isotretinoin in Severe Peanut- and Soy-Allergic Patients: Is it Safe or Not?. Journal of Investigational Allergology and Clinical Immunology. 29(2). 146–148. 5 indexed citations

13.

Timmers, Tessa, Rik Ossenkoppele, Emma E. Wolters, et al.. (2019). Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum. Alzheimer s Research & Therapy. 11(1). 60–60. 32 indexed citations

14.

Verberk, Inge M.W., Rosalinde E.R. Slot, Sander C.J. Verfaillie, et al.. (2018). Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes. Annals of Neurology. 84(5). 648–658. 219 indexed citations

15.

Verfaillie, Sander C.J., Rosalinde E.R. Slot, Ellen Dicks, et al.. (2018). A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline. Human Brain Mapping. 39(8). 3143–3151. 39 indexed citations

16.

Tijms, Betty M., Mara ten Kate, Alida A. Gouw, et al.. (2017). Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease. Neurobiology of Aging. 61. 75–81. 44 indexed citations

17.

Fällmar, David, Sven Haller, Johan Lilja, et al.. (2017). Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET. European Radiology. 27(10). 4237–4246. 31 indexed citations

18.

Adriaanse, Sofie M., Alle Meije Wink, Betty M. Tijms, et al.. (2015). The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease. Brain Connectivity. 6(1). 1–8. 16 indexed citations

19.

Verfaillie, Sander C.J., Sofie M. Adriaanse, Maja Binnewijzend, et al.. (2014). P2‐196: RESTING STATE CEREBRAL PERFUSION AND METABOLISM IN SUBJECTIVE MEMORY COMPLAINTS: ALZHEIMER'S DISEASE AND FRONTOTEMPORAL DEMENTIA–TWO SIDES OF THE SAME COIN?. Alzheimer s & Dementia. 10(4S_Part_14). 1 indexed citations

20.

Popescu, Veronica, Marco Battaglini, Sander C.J. Verfaillie, et al.. (2012). Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis. NeuroImage. 61(4). 1484–1494. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact